Broad Institute
Fetal Exome Sequencing Studies Point to Noninvasive Prenatal Screening Applications
New research suggests trio exome sequencing on parental DNA samples and cell-free DNA from maternal plasma can successfully uncover clinically relevant fetal variants.
Named Broad Clinical Labs, the center continues to target institutional and industrial customers who require large-scale clinical genomic testing.
The method, based on the protocol set by Aviv Regev, is a step toward enabling more genome-wide, rather than targeted, genetic perturbation screens.
Rheumatoid Arthritis Inflammatory Subtypes, Treatment Responses Uncovered in Synovial Tissue Study
With the help of single-cell RNA sequencing, single-cell CITE-seq, and other approaches, researchers saw six synovium-based inflammatory subtypes marked by distinct cell states.
Gates Foundation Awards Multiple Omics, Dx Grants in October, Including $9M for Co-Diagnostics
Awardees include Co-Diagnostics, Quantigen, the African Society for Laboratory Medicine, Broad Institute, and Antibody Solutions.